Monitor for prospectus supplements that would specify offering size and terms. The strong earnings and raised guidance provide a buffer, but any equity issuance could pressure the stock. The shelf is a routine administrative filing for now.
Price Chart
Executive Summary
Guardian Pharmacy filed an automatic shelf registration (S-3ASR) to register an indeterminate amount of Class A common stock for future sale by the company or selling stockholders. No immediate offering is announced; the filing provides flexibility for potential capital raises. Concurrent Q1 2026 earnings showed strong results with revenue up 2% YoY to $336.6M and EPS of $0.21 (vs $0.15 prior), with raised full-year EBITDA guidance, suggesting this shelf is opportunistic rather than distress-driven.
Key Facts
- S-3ASR filed on May 6, 2026 as a well-known seasoned issuer (WKSI)
- Registration covers an indeterminate amount of Class A common stock, with registration fee deferred under Rule 457(r)
- Proceeds from selling stockholders (if any) will not go to the company
- Q1 2026 revenue $336.6M (+2.2% YoY), net income $13.3M (+41% YoY), diluted EPS $0.21
- Full-year 2026 Adjusted EBITDA guidance raised to $123M-$127M (from $120M-$124M)
- Balance sheet solid: $64.9M cash, $232.4M equity, no long-term debt
Financial Impact
No immediate offering; potential future dilution depends on size and pricing of any takedown.
Risk Factors
- Future share issuance could dilute existing holders
- Selling stockholder registrations may signal insider monetization
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3ASR Filing (Primary) | 0001193125-26-209206 |
| Document: d339902dexfilingfees.htm | 0001193125-26-209206 |
| Document: d339902dex51.htm | 0001193125-26-209206 |
| Document: d339902dex231.htm | 0001193125-26-209206 |
| Document: 0001193125-26-209206-index-headers.html | 0001193125-26-209206 |
| Document: 0001193125-26-209206-index.html | 0001193125-26-209206 |
| Document: 0001193125-26-209206.txt | 0001193125-26-209206 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 9, 2026 11w ago | Institutional Cluster | $41.47 $42.45 | ▲ +2.36% | ▲ +3.28% | $39.26 (−5.33%) |
Jun 22, 2026 18w ago | 8-K | $39.19 $39.78 | ▲ +1.51% | ▲ +0.35% | $39.26 (+0.18%) |
Jun 11, 2026 19w ago | Institutional Cluster | $43.08 $41.06 | ▼ −4.69% | ▼ −6.58% | $39.26 (−8.87%) |
May 28, 2026 21w ago | 8-K | $38.74 $40.44 | ▲ +4.39% | ▲ +6.18% | $39.26 (+1.34%) |
May 6, 2026 24w ago | S-3ASR | $36.27 $39.14 | ▲ +7.91% | ▲ +4.78% | $39.26 (+8.24%) |
May 6, 2026 24w ago | 8-K | $36.27 $39.14 | ▲ +7.91% | ▲ +4.78% | $39.26 (+8.24%) |
Mar 26, 2026 30w ago | DEFA14A | $35.40 $37.57 | ▲ +6.13% | ▼ −4.54% | $39.26 (+10.90%) |
Mar 20, 2026 31w ago | Insider Cluster | $35.62 $37.34 | ▼ −4.83% | ▲ +4.49% | $39.26 (−10.22%) |
Feb 28, 2026 34w ago | Institutional Cluster | $33.66 $37.25 | ▲ +10.67% | ▲ +18.60% | $39.26 (+16.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers